A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy.
Conclusions:Our study provides a validated SCD risk prediction model with over 70% prediction accuracy and incorporates risk factors that are unique to pediatric HCM. An individualized risk prediction model has the potential to improve the application of clinical practice guidelines and shared decision-making for ICD insertion. Clinical Trial Registration:URL: https://clinicaltrials.gov Unique Identifier: NCT04036799.
PMID: 32418493 [PubMed - as supplied by publisher]
Source: Circulation - Category: Cardiology Authors: Miron A, Lafreniere-Roula M, Fan CS, Armstrong KR, Dragulescu A, Papaz T, Manlhiot C, Kaufman B, Butts RJ, Gardin L, Stephenson EA, Howard TS, Aziz PF, Balaji S, Beauséjour Ladouceur V, Benson LN, Colan SD, Godown J, Henderson HT, Ingles J, Jeewa A, Jeff Tags: Circulation Source Type: research
More News: Cardiology | Cardiomyopathy | Children | Clinical Trials | Genetics | Heart | Hypertrophic Cardiomyopathy | Pediatrics | Statistics | Study | Ventricular Tachycardia